Jane Street’s Regencell Bioscience RGC Stock Holding History
Bought
Maintained
Sold
Other funds holding RGC
Jane Street's RGC Position: Q3 2026 in Review
Jane Street reduced its Regencell Bioscience (RGC) stake by 17% in Q3 2026, selling an estimated $96.3K and leaving 81,697 shares worth $508K. The position accounts for ﹤0.01% of the portfolio, ranked #7983.
Jane Street first reported a position in RGC in Q3 2025 and has held it in 3 quarters since. The position peaked at $599K in Q2 2026. 31 funds tracked by Wall St. Rank hold RGC as of Q3 2026.
- Jane Street held 81,697 shares of Regencell Bioscience worth $508K as of Q3 2026.
- Jane Street sold 16,651 Regencell Bioscience shares in Q3 2026, an estimated $96.3K.
- Regencell Bioscience made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #7983 holding.
- Jane Street first reported a position in Regencell Bioscience in Q3 2025 and has held it in 3 quarters since.
- Jane Street's Regencell Bioscience position peaked at $599K in Q2 2026.
- 31 funds tracked by Wall St. Rank held Regencell Bioscience as of Q3 2026.
Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.